Last Updated: September 28, 2026

Details for Patent: 8,338,429


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 8,338,429
Title:2-acylaminothiazole derivative or salt thereof
Abstract:A 2-acylaminothiazole derivative or a pharmaceutically acceptable salt thereof having an excellent effect of proliferating human c-mpl-Ba/F3 cells and an activity of increasing platelets based on the effect of promoting the formation of megakaryocytic colonies. A compound or a pharmaceutically acceptable salt thereof useful in treating thrombocytopenia.
Inventor(s):Keizo Sugasawa, Susumu Watanuki, Yuji Koga, Hiroshi Nagata, Ryutaro Wakayama, Fukushi Hirayama, Ken-ichi Suzuki
Assignee: Astellas Pharma Inc
Application Number:US12/615,968
Patent Claim Types:
see list of patent claims
Use; Composition; Dosage form;

Drugs Protected by US Patent 8,338,429

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Foreign Priority and PCT Information for Patent: 8,338,429

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
Japan2002-10413Jan 18, 2002
Japan2002-10447Jan 18, 2002

International Family Members for US Patent 8,338,429

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
European Patent Office 1466912 ⤷  Start Trial CA 2019 00057 Denmark ⤷  Start Trial
European Patent Office 1466912 ⤷  Start Trial 2019C/547 Belgium ⤷  Start Trial
European Patent Office 1466912 ⤷  Start Trial 301020 Netherlands ⤷  Start Trial
European Patent Office 1466912 ⤷  Start Trial LUC00137 Luxembourg ⤷  Start Trial
European Patent Office 1466912 ⤷  Start Trial 122019000107 Germany ⤷  Start Trial
European Patent Office 1466912 ⤷  Start Trial 1990057-0 Sweden ⤷  Start Trial
European Patent Office 1466912 ⤷  Start Trial 132019000000157 Italy ⤷  Start Trial
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.